Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-High Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02764593
What this trial is testing

Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
RTOG Foundation, Inc. 40
Not applicableLooking for participantsNCT03836196
What this trial is testing

Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT05821088
What this trial is testing

Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma

Who this might be right for
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+19 more
David Bond, MD
Not applicableNot Yet RecruitingNCT07287046
What this trial is testing

A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis

Who this might be right for
Plantar Fasciitis
Mahidol University 28
Large-scale testing (Phase 3)UnknownNCT00175396
What this trial is testing

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy

Who this might be right for
Prostate Cancer
University of British Columbia 400
Not applicableStudy completedNCT07786064
What this trial is testing

Comparative Study of the Postprandial Glycemic Profile After Consumption of a High-fat Meal (Pizza) Between the Open-loop System (Medtronic MiniMed 640G) and the Hybrid Closed-loop System (Medtronic MiniMed 780G) in Patients With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Pumps.

Who this might be right for
Type 1 Diabetes Mellitus
Konstantinos Makrilakis, MD 20
Very early researchActive Not RecruitingNCT02603887
What this trial is testing

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 20
Post-approval studies (Phase 4)Study completedNCT05414201
What this trial is testing

Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uveitis

Who this might be right for
Non-infectious Intermediate Posterior- or Pan-uveitis
AbbVie 87
Testing effectiveness (Phase 2)Study completedNCT00000801
What this trial is testing

Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Testing effectiveness (Phase 2)Looking for participantsNCT07646145
What this trial is testing

Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Shanxi Province Cancer Hospital 30
Large-scale testing (Phase 3)Ended earlyNCT00133302
What this trial is testing

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Who this might be right for
Non-Hodgkin's Lymphoma
Japan Clinical Oncology Group 450
Not applicableUnknownNCT04492137
What this trial is testing

Prospective Comparison Between Ultra Early NKF Versus Standard Cannulation Alone

Who this might be right for
Pancreatitis
University of Minho 334
Early research (Phase 1)Study completedNCT01927224
What this trial is testing

Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients

Who this might be right for
Chagas Disease
Bayer 37
Not applicableUnknownNCT02497573
What this trial is testing

Can DW MRI Predict Outcome During Radiotherapy for Head and Neck Cancer?

Who this might be right for
Head and Neck Cancer
NHS Greater Glasgow and Clyde 80
Not applicableLooking for participantsNCT06143969
What this trial is testing

Ultrasound-assisted, Catheter-directed Thrombolysis for Acute Intermediate-high-risk Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Niguarda Hospital 180
Large-scale testing (Phase 3)Looking for participantsNCT05019846
What this trial is testing

SRT Versus SRT+ADT in Prostate Cancer

Who this might be right for
Prostate Cancer
Marco Lorenzo Bonu 310
Not applicableStudy completedNCT04846049
What this trial is testing

Inter-Disciplinary Outpatient Care Model Providing Comprehensive Geriatric Assessment, Care-Coordination & Co-management

Who this might be right for
VeteransGeriatric AssessmentCare-Coordination+1 more
Miami VA Healthcare System 206
Testing effectiveness (Phase 2)Study completedNCT02874014
What this trial is testing

Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 56
Not applicableStudy completedNCT02846038
What this trial is testing

Understanding Communication in Healthcare to Achieve Trust (U-CHAT)

Who this might be right for
Brain TumorsSolid Tumor
St. Jude Children's Research Hospital 138
Testing effectiveness (Phase 2)Study completedNCT03886415
What this trial is testing

Jaktinib Hydrochloride Tablets in Intermediate-risk and High-risk Myelofibrosis.

Who this might be right for
Myelofibrosis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 118
Next Page
37